Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Summary: Joint pain is not established as a direct side effect of Mounjaro (tirzepatide), though musculoskeletal symptoms occur in 3-7% of patients at rates similar to placebo
Plans still must cover at least two drugs per class and all drugs in the protected classes
What likely matters more than the dose itself is the rate of weight loss
Tirzepatide Cholesterol Changes Clinical Trial Data The SURMOUNT program
Assuming just 10% of eligible beneficiaries use Wegovy in a given year, and assuming a 50% rebate on the list price, Medicare would incur nearly $3 billion in additional net Part D spending for one year for this one drug alone.KFF also finds that beneficiaries who take Wegovy could face monthly out-of-pocket costs of $325 to $430 if they have to pay a percentage of the drugs $1,300 list price for a months supply
And if youre looking for an easy way to start
